Therapeutically promising new findings for combating hypertension and cardiovascular disease

Researchers from Wisconsin and Texas identify benefits of certain EET analogs

2011-04-12

(Press-News.org) WASHINGTON – More than one-third of the world's population suffers from hypertension (commonly known as high blood pressure) and cardiovascular disease (disorders that affect the heart and/or blood vessels). The U.S. Agency for Healthcare Quality and Research has reported that Americans spent $29 billion for non-prescription cardiovascular drugs alone in 2008. With the number of individuals afflicted on the rise, and the costs for treatment on the increase, scientists and policymakers are looking for new approaches to combat these disorders.

A team of Wisconsin and Texas scientific researchers have discovered a promising new avenue they strongly believe can be further developed to treat the diseases. The researchers are Md Abdul Hye Khan, William B. Campbell and John D. Imig of the Medical College of Wisconsin, Milwaukee, and Vijaya L. Manthati, Jawahar L. Jat, and John R. Falck of the University of Texas Southwestern Medical Center, Dallas.

Drs. Khan and Imig will discuss the team's findings based on their research paper, "Novel Epoxyeicosatrienoic Acid Analogs Increase Sodium Excretion and Lower Blood Pressure in Hypertension," at the 2011 Experimental Biology meeting (EB 2011), being held April 9-13, 2011 at the Washington, DC Convention Center.

Two EET Analogs Found to Lower Blood Pressure, Reduce Kidney Injury

Key to the research is the role of endothelial cells, which line the narrow spaces of the body such as those inside the blood vessels and the heart. Endothelial cells produce arachidonic acid metabolites, a class of fatty acids that have biological actions that are beneficial for cardiovascular health. This production occurs through three primary enzymatic pathways. Two of these pathways, the cyclooxygenase and the lipoxygenase pathways, have been successfully targeted for the treatment of inflammation, pain, fever, and asthma.

The third enzymatic pathway is the cytochrome P450 pathway that produces epoxyeicosatrienoic acids (EETs) as major biologically active metabolites. EETs are endothelial-derived factors that significantly influence cardiovascular function. They can dilate blood vessels, lower blood pressure and have additional biologic actions including anti-inflammatory and anti-platelet aggregator activity. These biological activities have made EETs a very attractive therapeutic target for cardiovascular diseases.

For the last several years the research team has developed and synthesized an array of EET analogs, or chemical compounds that act as EETs. The EET analogs have been tested for beneficial cardiovascular actions. For this research study 35 different EET analogs were screened for their ability to dilate blood vessels. The screening produced five EET analogs that would be further examined to determine their ability to lower blood pressure in animal models of hypertension. Two of the five EET analogs administered to hypertensive animals effectively lowered blood pressure and reduced kidney injury.

Next Steps

According to Dr. Imig, "This work is a major step forward in obtaining our goal to develop novel EET analogs for the treatment of cardiovascular disease." He added, "We strongly believe that these EET analogs are therapeutically promising and can be further developed as a novel treatment for hypertension and cardiovascular disease."

The next steps, according to Dr. Imig, are to test the EET analogs in other cardiovascular diseases and improve EET analog formulation for potential future use in humans.

### About Experimental Biology 2011 Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 13,000-plus independent scientists and exhibitors. The American Society for Pharmacology and Experimental Therapeutics (ASPET) is a co-sponsor of the meeting along with the American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP) and American Society for Nutrition (ASN).

About the American Society for Pharmacology and Experimental Therapeutics The American Society for Pharmacology and Experimental Therapeutics (ASPET), is a 4,500 member scientific society. ASPET members discover and develop new medicines and therapeutic agents that fight existing and emerging diseases as well as increase the understanding of therapeutics work in humans.

NOTE TO EDITORS: To request an interview with Drs. Imig or Khan please contact Donna Krupa at dkrupa@the-aps.org or 301-634-7209.

ELSE PRESS RELEASES FROM THIS DATE:

Primary care targeted for suicide prevention efforts

2011-04-12

Forty-five percent of the 32,000 Americans who take their own lives each year visit their primary care provider within one month of their death. Ninety percent have a mental health or substance abuse disorder, or both. Yet only in the last decade has suicide been considered a preventable public health problem. "In our society, we have separated mental health and physical health for quite some time," said Dr. Judith Salzer, Associate Dean for Strategic Management at the Georgia Health Sciences University College of Nursing. Salzer, a primary care pediatric nurse practitioner ...

Pharmacogenetics testing offers way to reduce deaths from drug toxicity

2011-04-12

On average, a drug on the market works effectively for only 50% of the people who take it. Would you want to prevent a potential adverse drug effect or even toxicity through a simple test? It's not science fiction, but a reality. Pharmacogenetics (PGx) is the study of an individual's variation in DNA sequence related to drug response. The goal is to select the right drug at the right dose, and to avoid adverse drug reactions or ineffective treatment. Dr. Tara Sander, Associate Professor of Pathology, Pediatric Pathology, Medical College of Wisconsin, and Scientific Director ...

Empire Medical Training Offers Great New Way to Train Your Medical Staff - Send 3 Office Members at a Time

2011-04-12

Empire Medical Training - a recognized source for CME Education and Procedural Training for the past 10 years - knows how difficult it can be to schedule trainings for a larger practice. That's why they've created their Office Membership Program. A great new way to train staff, large practices can send up to three staff members to all of Empire's training programs - including their incredibly popular Advanced Aesthetic Workshop - over the course of two years - all for one incredibly low price. About Empire Medical Training's Office Membership Program: Instead of ...

Tissue engineers use new system to measure biomaterials, structures

2011-04-12

PROVIDENCE, R.I. [Brown University] — Tissue engineering makes biologists builders, but compared to their civil engineering counterparts, they don't know much about the properties of the materials and structures they use, namely living cells. To improve that knowledge, Brown University researchers have developed a simple and reliable system for measuring the power that cells employ to assemble into three-dimensional tissue. The research appears online the week of April 11 in Proceedings of the National Academy of Sciences. In addition to helping engineers evaluate how ...

Distribution of cancers in the HIV/AIDS population is shifting

2011-04-12

As treatments for HIV/AIDS improve and patients are living longer, the distribution of cancers in this population has undergone a dramatic shift in the United States. While cases of the types of cancer that have been associated with AIDS progression have decreased, cases of other types of cancer are on the rise. These results, reported by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Disease Control and Prevention, were published online April 11, 2011, in the Journal of the National Cancer Institute. The ...

UCSF study on multitasking reveals switching glitch in aging brain

2011-04-12

Scientists at the University of California, San Francisco have pinpointed a reason older adults have a harder time multitasking than younger adults: they have more difficulty switching between tasks at the level of brain networks. Juggling multiple tasks requires short-term, or "working," memory – the capacity to hold and manipulate information in the mind for a period of time. Working memory is the basis of all mental operations, from learning a friend's telephone number, and then entering it into a smart phone, to following the train of a conversation, to conducting ...

Brighter Future for Planet is The Goal as Sheraton Sharm El Sheikh Goes Dark for Earth Hour 2011

2011-04-12

By spending an hour in the dark on March 26th, Sheraton Sharm El Sheikh joined millions around the world to send a powerful message about a brighter future for the planet. Sheraton Sharm El Sheikh turned off its lights in observance of Earth Hour, the global environmental awareness event created by the World Wildlife Fund (WWF). Last year, Earth Hour 2010 became the biggest Earth Hour ever. A record 128 countries and territories joined the global display of climate action. Iconic buildings and landmarks from Asia Pacific to Europe and Africa to the Americas switched ...

Combined use of 3 markers for kidney disease may help predict risk of kidney failure, death

2011-04-12

Combining the chronic kidney disease markers of creatinine-based estimated glomerular filtration rate and urine albumin-to-creatinine ratio with the biomarker cystatin C was associated with improved prediction of end-stage kidney disease and all-cause death, according to a study that will appear in the April 20 issue of JAMA. The study is being published early online to coincide with its presentation at the World Congress of Nephrology. Chronic kidney disease (CKD) is currently defined as certain levels of creatinine-based estimated glomerular filtration rate (GFR) or ...

Routine lab test data predicts progression to kidney failure for chronic kidney disease patients

2011-04-12

A prediction model that included data on measures of several routinely obtained laboratory tests including blood levels of calcium, phosphate and albumin accurately predicted the short-term risk of kidney failure for patients with moderate to severe chronic kidney disease, according to a study that will appear in the April 20 issue of JAMA. The study is being published early online to coincide with its presentation at the World Congress of Nephrology. "An estimated 23 million people in the United States (11.5 percent of the adult population) have chronic kidney disease ...

Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease

2011-04-12

An analysis of studies involving the drug memantine finds a lack of evidence for benefit when the drug is used to treat patients with mild Alzheimer disease, according to a report posted online today that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals. "Memantine, indicated for moderate to severe Alzheimer disease (AD), is frequently prescribed off-label [for uses other than those approved by the FDA] either alone or with a cholinesterase inhibitor for mild AD and mild cognitive impairment," the authors write as background ...

Therapeutically promising new findings for combating hypertension and cardiovascular disease

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: